CHPF

chondroitin polymerizing factor, the group of Beta 4-glycosyltransferases|Beta 3-glycosyltransferases

Basic information

Region (hg38): 2:219538954-219543809

Links

ENSG00000123989NCBI:79586OMIM:610405HGNC:24291Uniprot:Q8IZ52AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CHPF gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CHPF gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
50
clinvar
2
clinvar
1
clinvar
53
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 50 2 2

Variants in CHPF

This is a list of pathogenic ClinVar variants found in the CHPF region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-219539397-C-T not specified Uncertain significance (Oct 03, 2022)2374073
2-219539432-G-T not specified Uncertain significance (Oct 14, 2023)3144511
2-219539477-T-G not specified Uncertain significance (Jun 22, 2024)3267096
2-219539490-T-C not specified Uncertain significance (Jun 16, 2024)3267095
2-219539499-C-T not specified Uncertain significance (May 18, 2023)2521473
2-219539517-G-A not specified Uncertain significance (Apr 04, 2024)3267094
2-219539522-C-T not specified Uncertain significance (Nov 09, 2021)2394960
2-219539546-G-A not specified Uncertain significance (Jan 02, 2024)3144509
2-219539565-T-C not specified Likely benign (Dec 03, 2021)3144508
2-219539577-G-A not specified Uncertain significance (Sep 22, 2023)3144507
2-219539580-A-T not specified Uncertain significance (Aug 04, 2023)2616352
2-219539612-T-A not specified Uncertain significance (Oct 06, 2021)3144506
2-219539613-C-T not specified Uncertain significance (Oct 06, 2021)2377151
2-219539614-C-T Benign (Dec 31, 2019)786494
2-219539616-C-G not specified Uncertain significance (Sep 29, 2023)3144505
2-219539619-C-G not specified Uncertain significance (Aug 02, 2021)2403995
2-219539619-C-T not specified Uncertain significance (Aug 16, 2021)2239257
2-219539625-C-G not specified Uncertain significance (May 23, 2023)2507567
2-219539685-C-T not specified Uncertain significance (Dec 14, 2023)3144503
2-219539765-G-C not specified Uncertain significance (Apr 01, 2024)3267087
2-219539785-C-T not specified Uncertain significance (Jan 23, 2024)3144502
2-219539800-C-G not specified Uncertain significance (Jan 04, 2022)2269543
2-219539831-C-T not specified Uncertain significance (Jul 11, 2023)2592191
2-219539868-C-T not specified Uncertain significance (Jul 20, 2021)2238532
2-219539969-C-T not specified Uncertain significance (Feb 17, 2022)2277435

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CHPFprotein_codingprotein_codingENST00000243776 44841
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.1510.8491256780681257460.000270
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.034194830.8680.00003174803
Missense in Polyphen87113.40.76721155
Synonymous1.181882100.8960.00001251762
Loss of Function3.33623.40.2570.00000143218

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003640.000360
Ashkenazi Jewish0.000.00
East Asian0.00005460.0000544
Finnish0.000.00
European (Non-Finnish)0.0005080.000484
Middle Eastern0.00005460.0000544
South Asian0.00006880.0000653
Other0.0001710.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has both beta-1,3-glucuronic acid and beta-1,4-N- acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Isoform 2 may facilitate PRKN transport into the mitochondria. In collaboration with PRKN, isoform 2 may enhance cell viability and protect cells from oxidative stress. {ECO:0000269|PubMed:12761225}.;
Pathway
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate - Homo sapiens (human);Metabolism of carbohydrates;Chondroitin sulfate biosynthesis;Chondroitin sulfate/dermatan sulfate metabolism;Glycosaminoglycan metabolism;chondroitin sulfate biosynthesis (late stages);Proteoglycan biosynthesis;chondroitin sulfate biosynthesis;dermatan sulfate biosynthesis;Metabolism;chondroitin and dermatan biosynthesis (Consensus)

Recessive Scores

pRec
0.196

Intolerance Scores

loftool
rvis_EVS
-0.86
rvis_percentile_EVS
10.89

Haploinsufficiency Scores

pHI
0.140
hipred
Y
hipred_score
0.597
ghis
0.532

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.323

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Chpf
Phenotype
limbs/digits/tail phenotype; skeleton phenotype; normal phenotype;

Gene ontology

Biological process
chondroitin sulfate biosynthetic process
Cellular component
Golgi membrane;mitochondrial matrix;cytosol;integral component of membrane;Golgi cisterna membrane
Molecular function
metal ion binding;glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity;N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity